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Background & Objectives: Lipopolysaccharide (LPS) as an endotoxin is a strong stimulator 
of nitric oxide (NO) production in monocytes/macrophages. NO has been shown to be an 
important inducer of inflammation. Verapamil, a calcium channel blocker, has been widely 
used in treatment of cardiovascular diseases. Moreover the anti-inflammatory properties of 
verapamil have been demonstrated. In this study the effect of verapamil on LPS-induced NO 
production in a human monocytic cell line has been investigated in vitro. 
Methods: The human monocytic THP1 cells were cultured in complete RPMI medium. The 
cells at logarhytmic growth phase were stimulated with LPS at optimum concentration and 
then incubated with different concentrations of verapamil (0.001-1000 µg/ml). Afterward the 
NO production in cell culture supernates was measured by the Griss assay.   
Results: Verapamil significantly decreased the NO production in LPS-stimulated THP1 cells 
in a dose-dependent manner. 
Conclusion: The results of the present study showed that verapamil down-regulates the NO 
production in human monocytic THP-1 cells. So the anti-inflammatory properties of 
verapamil may be partly due to its inhibitory effects on NO production. Verapamil might 
have potential implication in planning of therapeutic approaches for NO-mediated 
inflammatory disorders. 
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